| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Ernexa Therapeutics Inc.
13G/A
Amendment 7
ERNA · 114082407
|
7.0% |
10/30/2026
Event 8/5/2026
|
|||
| Freebird Partners LP | 7.0% | ||||
| Freebird Investments LLC | 7.0% | ||||
| Curtis Huff | 7.0% | ||||
|
Ernexa Therapeutics Inc.
13G/A
Amendment 6
ERNA · 114082407
|
9.9% |
5/15/2026
Event 2/10/2026
|
|||
| Freebird Partners LP | 9.9% | ||||
| Freebird Investments LLC | 9.9% | ||||
| Curtis Huff | 9.9% | ||||
|
Ernexa Therapeutics Inc.
13G/A
Amendment 5
ERNA · 114082308
|
9.9% |
12/19/2025
Event 12/19/2025
|
|||
| Freebird Partners LP | 9.9% | ||||
| Freebird Investments LLC | 9.9% | ||||
| Curtis Huff | 9.9% | ||||
|
Ernexa Therapeutics Inc.
13G/A
Amendment 4
ERNA · 114082209
|
9.9% |
5/14/2025
Event 3/31/2025
|
|||
| Freebird Partners LP | 9.9% | ||||
| Freebird Investments LLC | 9.9% | ||||
| Curtis Huff | 9.9% | ||||
|
Eterna Therapeutics Inc.
13G/A
Amendment 3
ERNA · 114082209
|
10.0% |
1/28/2025
Event 10/29/2024
|
|||
| Freebird Partners LP | 10.0% | ||||
| Freebird Investments LLC | 10.0% | ||||
| Curtis Huff | 10.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.